You have 9 free searches left this month | for more free features.

Neoadjuvant Treatments

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Nasopharyngeal Carcinoma Trial in Shanghai (Camrelizumab, Nimotuzumab, neoadjuvant chemo and CCRT)

Recruiting
  • Nasopharyngeal Carcinoma
  • Shanghai, Shanghai, China
    Fudan Universtiy Shanghai Cancer Centre
Mar 6, 2023

Colorectal Cancer Trial (Ezabenlimab, BI 765063, Pembrolizumab)

Recruiting
  • Colorectal Cancer
  • New York, New York
    Mount Sinai School of Medicine
Jan 10, 2023

Breast Cancer Trial in Madrid (Vacuum-assisted breast biopsy)

Unknown status
  • Breast Cancer
  • Vacuum-assisted breast biopsy
  • Madrid, Spain
    ClĂ­nica Universidad de Navarra
Mar 11, 2021

Neoadjuvant Therapy Trial (standard long-term therapy, FOLFOX and standard long-term radiotherapy, FOLFIRI and standard

Not yet recruiting
  • Neoadjuvant Therapy
  • standard long-term therapy
  • +5 more
  • (no location specified)
Apr 22, 2022

Clinical Treatments for Patients With Oropharyngeal Carcinoma

Recruiting
  • Oropharynx Carcinoma
  • Surgery for early-stage OPC
  • +4 more
  • Shanghai, Shanghai, China
    Department of Otorhinolaryngology, Eye & ENT Hospital
Apr 18, 2022

Rectal Carcinoma Trial in France (50 Gy, Capecitabine, 25 Gy)

Completed
  • Rectal Carcinoma
  • 50 Gy
  • +2 more
  • Abbeville, France
  • +36 more
Jul 26, 2022

s in Specialized Disease of Laryngeal Carcinoma and

Recruiting
  • Glottic Carcinoma
  • +5 more
  • routines
  • Shanghai, Shanghai, China
    Lei Tao
May 26, 2021

Testing Tumor Tissue and Blood to Help Select Personalized

Not yet recruiting
  • NSCLC
  • ctDNA, tumor NGS
  • (no location specified)
Mar 2, 2021

Surgical Complications and DFS in Obese Rectal Cancer Patients

Recruiting
  • Obesity, Morbid
  • +2 more
  • BIB positioning
  • Naples, Italy
    Nunzio Velotti
Sep 27, 2023

Pulsed Time-Domain Optical Spectroscopy for Monitoring Responses

Recruiting
  • Breast Cancer
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    Sep 18, 2019

    Colorectal Cancer Stage II, Colorectal Cancer Stage III, Mmr Deficiency Trial in Guangzhou (drug, radiation, procedure, other)

    Active, not recruiting
    • Colorectal Cancer Stage II
    • Colorectal Cancer Stage III
    • Guangzhou, Guangdong, China
      Medical Oncology,Sun Yat-sen University Cancer Center
    Jan 29, 2023

    Surgery After Neoadjuvant Chemotherapy in Locally Advanced

    Completed
    • Postoperative Complications
    • surgery after neoadjuvant chemotherapy
    • Seoul, Korea, Republic of
      Asan medical center
    Jun 1, 2023

    Breast Cancer, Radiotherapy Trial in Bologna (SBRT anticipated boost)

    Recruiting
    • Breast Cancer
    • Radiotherapy
    • SBRT anticipated boost
    • Bologna, Italy
      IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Jan 9, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Baltimore (Pembrolizumab, IO102-103)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Baltimore, Maryland
      Johns Hopkins University
    Aug 2, 2023

    Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • Xiaopi granules
    • +2 more
    • (no location specified)
    Nov 22, 2023

    Hepatocellular Carcinoma Resectable Trial in Fuzhou (neoadjuvant therapy)

    Not yet recruiting
    • Hepatocellular Carcinoma Resectable
    • neoadjuvant therapy
    • Fuzhou, Fujian, China
      The First Affiliated Hospital of Fujian Medical University
    Aug 19, 2023

    Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, V937)

    Recruiting
    • Melanoma
    • Pembrolizumab
    • +5 more
    • Los Angeles, California
    • +28 more
    Jan 25, 2023

    Female Breast Cancer Trial in Sohag (Hormonal Antineoplastics, Chemotherapy drug)

    Not yet recruiting
    • Female Breast Cancer
    • Hormonal Antineoplastics
    • Chemotherapy drug
    • Sohag, Egypt
      amal Ali
    Feb 23, 2023

    Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer Trial in New Haven (Dapagliflozin 10mg)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Dapagliflozin 10mg
    • New Haven, Connecticut
      Yale Cancer Center Smilow Cancer Hospital
    Aug 3, 2023

    Locally Advanced Hypopharyngeal Carcinoma Trial in Shanghai (drug, procedure, radiation)

    Not yet recruiting
    • Locally Advanced Hypopharyngeal Carcinoma
    • three cycles (toripalimab + cetuximab + platinum)
    • +2 more
    • Shanghai, Shanghai, China
      Eye & ENT Hospital of Fudan University
    Nov 22, 2023

    NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Yangzhou, Jiangsu, China
      People's hospital of northern jiangsu
    Sep 26, 2023

    Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy

    Recruiting
    • Muscle-Invasive Bladder Carcinoma
    • +2 more
    • cisplatin based neoadjuvant chemotherapy
    • Radical cystectomy alone
    • Rome, Italy
      Riccardo Mastroianni
    Mar 8, 2023

    Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)

    Not yet recruiting
    • Merkel Cell Carcinoma
    • Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
    • Wollstonecraft, New South Wales, Australia
      Melanoma Institute Australia
    Nov 21, 2023

    Colon Cancer Trial (Neoadjuvant chemo)

    Not yet recruiting
    • Colon Cancer
    • Neoadjuvant chemotherapy
    • (no location specified)
    Oct 25, 2023

    Locally Advanced Rectal Carcinoma Trial (Short course radiotherapy with concurrent capecitabine(825mg/m2), Long course

    Not yet recruiting
    • Locally Advanced Rectal Carcinoma
    • Short course radiotherapy with concurrent capecitabine(825mg/m2)
    • Long course radiotherapy with concurrent capecitabine(825mg/m2)
    • (no location specified)
    Jun 24, 2023